As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
People who lose their visual imagination after a stroke share damage to a single neural circuit. A new analysis maps these ...
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
A warm body in the rainforest gives off a loud chemical signal. For most mosquitoes, that signal could belong to almost any ...
Although Duolingo suffered a severe drop following its Q4 earnings disclosure, the smart money seems intrigued by DUOL stock ...
More than half of transplant recipients in a large analysis developed chronic graft-versus-host disease, and 15% died from causes other than cancer relapse. Those numbers capture the uneasy truth of ...
The lab-scale, near-white heterojunction solar cell uses nanoclay-based scattering layers combined with dielectric multilayer films to preserve power conversion efficiency while enhancing visual ...
Macaque’s social tolerance grades, through its underlying cognitive demands, shape subcortical structures volumes.
Background Data-sharing mandates from funders and journals have increased in recent years, but little is known about how shared data are used. Existing research has focused on access frameworks, with ...
The trials in breast, lung, and colorectal cancer, supported by ARPA-H, will focus on guiding decisions across different lines of therapy using serial biopsies and tumor profiling.
Discover the hidden dangers of sycophantic AI. Learn why chatbots prioritize flattery over facts, the risks of delusional spiraling, and how to stop LLMs from simply telling you what you want to hear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results